Clinical Research

Clinical Research studies open to Capital Cardiology Associates patients

Clinical Research at Capital Cardiology Associates

Meet the team

Meet the Clinical Research team at Capital Cardiology Associates.

Dr Robert Benton

Dr. Scott Purga grew up in Schenectady. He graduated Summa Cum Laude from Boston University, College of Arts and Science with dual major in Medical Science and Psychology. While at Boston University, he was enrolled in the seven-year accelerated medical program, was a recipient of the Distinguished Sophomore Award (given to the Top 40 students of the class year), and honored Phi Beta Kappa. He received his medical degree from Boston University School of Medicine, where he was a recipient of the Anthony L.F. Gorman Prize in Physiology and honored Alpha Omega Alpha. While at Boston University, Dr. Purga was an Introduction to Clinical Medical Instructor. Dr. Purga’s post graduate training was at New York Presbyterian Hospital / Weill Cornell Medical Center with a residency in Internal Medicine. He subsequently completed a fellowship in Cardiovascular Disease at Albany Medical Center.

Read more on Dr. Scott Purga

Dr. Eugene Pashkovetsky graduated Cum Laude from State University of New York Stony Brook with a major in Biology and minor in Chemistry. While at Stoney Brook, he was also on the Dean’s List, a member of Phi Beta Kappa, the Golden Key Honor Society, and National Society of Collegiate Scholars. He received his medical degree from St. George’s University School of Medicine (Grenada, West Indies), where he also taught all materials in Microbiology to medical students. Dr. Pashkovetsky’s post graduate training was at Northwell Health – Lenox Hill Hospital with a residency in Internal Medicine.

Read Dr. Pashkovetsky’s full bio here

Dr Parag Shah
Dr Robert Benton

Dr. Parag Shah attended Guy’s Hospital in London, UK where he received his medical degree in 1987.  In 1995, he completed a Fellowship in Cardiology at Albany Medical Center in Albany, NY.

Dr. Shah is Board Certified in Cardiology. He is a Fellow of the American College of Cardiology. He is on staff at St. Peter’s Hospital and Albany Medical Center in Albany, NY.

Dr. Shah’s cardiology specialities include: general cardiovascular disease with a special interest in permanent pacemaker implantation and transesophageal echocardiograms.

Read more on Dr. Shah

Patricia Ryan RN, MSN Ed., PCCN is the CCA Clinical Research Manager. She brings five years of experience in acute and outpatient cardiology care to the department of research as a research coordinator/nurse. She received her Progressive Care Certification through The American Association of Critical Care Nursing in 2019. She obtained her Bachelor’s Degree in Nursing from Le Moyne College in 2017 and a Masters in Nursing Education through Western Governors University in 2021.

Thomas Spadola, LPN graduated from the Capital Region Boces LPN program in 2009. He has held various nursing jobs since 2009 and has been in research for 5 years. He is a lifelong resident of the Capital Region and is married with two children.

Current Clinical Research Studies

Capital Cardiology Associates is participating in the following clinical research studies

Explanation of current research studies and directions on how to participate

Click on the box to read more on the study and enrollment availability.

AMULET

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENCE OF MAJOR CARDIOVASCULAR EVENTS IN PATIENTS WITH, OR AT HIGH RISK
FOR, CARDIOVASCULAR DISEASE WHO ARE STATIN INTOLERANT

Read more on this study

Not currently accepting participants. 

CARE-HK (VIFOR)

This study is a multinational, multicentre, non-interventional, cohort study of assessment and treatment guideline recommendations in HF patient care in a real-world setting

Read more on this study

Now accepting patients!

ESPERION

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENCE OF MAJOR CARDIOVASCULAR EVENTS IN PATIENTS WITH, OR AT HIGH RISK
FOR, CARDIOVASCULAR DISEASE WHO ARE STATIN INTOLERANT

Read more on this study

Not currently accepting participants.

Inception

A randomized, controlled, multicenter, open-label trial
comparing a hospital post-discharge care pathway
involving aggressive LDL-C management that includes
inclisiran with usual care versus usual care alone in
patients with a recent acute coronary syndrome
(VICTORION-INCEPTION)

Read more on this study

Now accepting patients!

ORION-4

A double-blind randomized placebo-controlled trial assessing the effects of inclisiran on clinical outcomes among people with atherosclerotic cardiovascular disease

Read more on this study

Now accepting patients!

Portico
The Portico transcatheter aortic valve provides a minimally invasive treatment for patients diagnosed with severe aortic stenosis, an abnormal narrowing of the aortic valve. It is used in patients who may be at a high or extreme risk for open heart surgery

– Not a good candidate for surgical valve replacement
– Patient will either receive portico valve or commercially available valve

*In conjunction with Albany Medical Center

Read more on this study

Now accepting patients!

Partners 3
To establish the safety and effectiveness of the Edwards SAPIEN 3 transcatheter heart valve in patients with severe, calcific aortic stenosis who are at low operative risk for standard aortic valve replacement(AVR)

-Transcatheter Aortic Valve Replacement (TAVR) -VS- Surgical Aortic Valve Replacement (SAVR)
-10 year study

*In conjunction with Albany Medical Center

Read more on this study

Now accepting patients!